A Systemic Summary of Nanotechnology's Current and Prospective Scope in Drugs Delivery

Aditi Chaudhary; Ravi kumar; Ajit Kumar Varma1

1

Publication Date: 2023/07/20

Abstract: The creation of drug formulations based on nanoparticles offers the possibility to tackle and treat challenging diseases. The size of nanoparticles varies between 100 and 500 nm. By changing their size, surface characteristics, and structure, nanoparticles can be transformed into intelligent systems. The idea was put forth as a workable substitute with the ability to target and administer drugs. The use of nanobiotechnology in viral, autoimmune, and inflammatory diseases is numerous. Nanoparticles have biomimetic properties like medication formulation and encapsulation. Nanomaterials are substances based on graphene for stem cell and tissue engineering constitute a few of the most contemporary graphene developments.

Keywords: Nanotechnology, Future of Nanotechnology, Cancer Stem Cell(CSC), Gold Nanoparticles (AuNPs), Gold Nanorods (AuNRs), Drug Delivery Systems (DDs)

DOI: https://doi.org/10.5281/zenodo.8171198

PDF: https://ijirst.demo4.arinfotech.co/assets/upload/files/IJISRT23JUL392.pdf

REFERENCES

No References Available